RANKL antibody (N-Term)
Quick Overview for RANKL antibody (N-Term) (ABIN2856614)
Target
See all RANKL (TNFSF11) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Cross-Reactivity
- Mouse (Murine), Rat (Rattus), Cow (Bovine)
-
Cross-Reactivity (Details)
- Mouse (86 %), Rat (86 %), Bovine (100 %)
-
Characteristics
-
Rabbit polyclonal antibody to RANKL (CD254) (tumor necrosis factor (ligand) superfamily, member 11)
RANKL antibody [N1], N-term -
Purification
- Purified by antigen-affinity chromatography.
-
Immunogen
- Carrier-protein conjugated synthetic peptide encompassing a sequence within the N-terminus region of human RANKL. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Suggested dilution Reference Western blot 1:500-1:3000* Not tested in other applications. *Optimal dilutions/concentrations should be determined by the researcher.Suggested dilutionReferenceWestern blot1:500-1:3000*
-
Comment
-
Positive Control: A431 , HeLa , Molt-4 , Raji
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.3 mg/mL
-
Buffer
- 0.1M Tris, 0.1M Glycine, 10 % Glycerol ( pH 7). 0.01 % Thimerosal was added as a preservative.
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- RANKL (TNFSF11) (Tumor Necrosis Factor (Ligand) Superfamily, Member 11 (TNFSF11))
-
Alternative Name
- RANKL (CD254)
-
Background
-
This gene encodes a member of the tumor necrosis factor (TNF) cytokine family which is a ligand for osteoprotegerin and functions as a key factor for osteoclast differentiation and activation. This protein was shown to be a dentritic cell survival factor and is involved in the regulation of T cell-dependent immune response. T cell activation was reported to induce expression of this gene and lead to an increase of osteoclastogenesis and bone loss. This protein was shown to activate antiapoptotic kinase AKT/PKB through a signaling complex involving SRC kinase and tumor necrosis factor receptor-associated factor (TRAF) 6, which indicated this protein may have a role in the regulation of cell apoptosis. Targeted disruption of the related gene in mice led to severe osteopetrosis and a lack of osteoclasts. The deficient mice exhibited defects in early differentiation of T and B lymphocytes, and failed to form lobulo-alveolar mammary structures during pregnancy. Two alternatively spliced transcript variants have been found.
Cellular Localization: Isoform 1: Cell membrane, Single-pass type II membrane protein , Isoform 3: Cell membrane, Single-pass type II membrane protein , Isoform 2: Cytoplasm , Tumor necrosis factor ligand superfamily member 11 , soluble form: Secreted -
Molecular Weight
- 35 kDa
-
Gene ID
- 8600
-
Pathways
- NF-kappaB Signaling
Target
-